The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1616
ISSUE 1616
January 25, 2021
Antibacterial Drugs for Community-Acquired Pneumonia
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
January 25, 2021 (Issue: 1616)
Treatment of community-acquired pneumonia (CAP)
is usually empiric, with selected antibiotic regimens
directed against some of the most common causative
pathogens. Recommended empiric regimens are
listed in Table 2; recommended antibiotic dosages for
treatment of CAP are listed in Tables 3 and 4. Joint
guidelines for treatment of CAP by the American
Thoracic Society and the Infectious Diseases Society of
America (ATS/IDSA) were updated in 2019.
... more
- JP Metlay et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med 2019; 200:e45.
- Adult immunization. Med Lett Drugs Ther 2018; 60:73.
- Antiviral drugs for influenza for 2020-2021. Med Lett Drugs Ther 2020; 62:169.
- National Institutes of Health (NIH) COVID-19 Treatment Guidelines Panel. Coronavirus disease 2019 (COVID-19) treatment guidelines. Available at: https://covid19treatmentguidelines.nih.gov/. Accessed January 7, 2021.
- JP Metlay and GW Waterer. Treatment of community-acquired pneumonia during the coronavirus disease 2019 (COVID-19) pandemic. Ann Intern Med 2020; 173:304.
- Treatments considered for COVID-19. Med Lett Drugs Ther 2020. Available at: https://secure.medicalletter.org/downloads/1595e_table.pdf. Accessed January 7, 2021.
- FDA Drug Safety Communication: FDA review finds additional data supports the potential for increased long-term risks with antibiotic clarithromycin (Biaxin) in patients with heart disease. February 22, 2018. Available at: https://bit.ly/3omrXlH. Accessed January 7, 2021.
- In brief: More fluoroquinolone warnings. Med Lett Drugs Ther 2018; 60:136.
- RL Woosley et al. QT drugs list. Available at: www.crediblemeds.org. Accessed January 7, 2021.
- Omadacycline (Nuzyra) – a new tetracycline antibiotic. Med Lett Drugs Ther 2019; 61:74.
- Lefamulin (Xenleta) for community-acquired bacterial pneumonia. Med Lett Drugs Ther 2019; 61:145.
- GS Tansarli and E Mylonakis. Systematic review and meta-analysis of the efficacy of short-course antibiotic treatments for community-acquired pneumonia in adults. Antimicrob Agents Chemother 2018; 62:e00635-18.
- Corticosteroids in community-acquired pneumonia. Med Lett Drugs Ther 2020; 62:7.

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.
Would you like to read the rest of this article? Gain access below.
Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
- Print version published and mailed biweekly (26 issues/year)
- Unlimited online access to current and past issues (1988 - present)
- Mobile App for iOS, Android, and Kindle Fire
- FREE online per issue CME/CE
Purchase this article:
Title: Antibacterial Drugs for Community-Acquired Pneumonia
Article code: 1616b
Electronic, downloadable article - $45
Article code: 1616b
Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian